KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 127 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $527,000 | -3.1% | 155,009 | +7.2% | 0.05% | -88.8% |
| Q2 2018 | $544,000 | -33.2% | 144,564 | -27.4% | 0.48% | -31.9% |
| Q1 2018 | $814,000 | -16.9% | 199,089 | -5.5% | 0.71% | -42.6% |
| Q4 2017 | $980,000 | -12.1% | 210,666 | +34.1% | 1.23% | +720.0% |
| Q3 2017 | $1,115,000 | -1.8% | 157,065 | 0.0% | 0.15% | -11.8% |
| Q2 2017 | $1,136,000 | +0.3% | 157,065 | -14.6% | 0.17% | -15.8% |
| Q1 2017 | $1,133,000 | +16.3% | 183,907 | +10.6% | 0.20% | -30.6% |
| Q4 2016 | $974,000 | +73.3% | 166,223 | +57.0% | 0.29% | +7.0% |
| Q3 2016 | $562,000 | -8.3% | 105,877 | +14.4% | 0.27% | -40.2% |
| Q2 2016 | $613,000 | -3.8% | 92,536 | -32.2% | 0.46% | -48.2% |
| Q1 2016 | $637,000 | -7.5% | 136,472 | 0.0% | 0.88% | -53.6% |
| Q4 2015 | $689,000 | – | 136,472 | – | 1.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 1,605,800 | $16,026,000 | 4.65% |
| Baupost Group | 25,791,678 | $257,401,000 | 4.29% |
| 1492 Capital Management LLC | 264,297 | $2,638,000 | 1.67% |
| Cormorant Asset Management, LP | 826,000 | $8,243,000 | 1.10% |
| FALCON POINT CAPITAL, LLC | 251,137 | $2,506,000 | 0.85% |
| OAK RIDGE INVESTMENTS LLC | 3,291,711 | $32,851,000 | 0.70% |
| Knoll Capital Management, LLC | 200,000 | $1,996,000 | 0.64% |
| Rhenman & Partners Asset Management AB | 534,000 | $5,329,000 | 0.64% |
| Old West Investment Management, LLC | 79,667 | $795,000 | 0.55% |
| THREE BAYS CAPITAL LP | 1,284,000 | $12,814,000 | 0.53% |